Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezacaftor/Ivacaftor + Ivacaftor Effects on GI Function in CF
NCT04006873Phase 2Completed
- Sponsor
- Nottingham University Hospitals
- Start
- Sep 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tezacaftor, ivacaftor in cystic fibrosis (CF), sponsored by Nottingham University Hospitals. Started Sep 2019; status: completed.
02
Drugs
tezacaftorivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT04006873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04006873.